Citations

Showing 10 of 108094 citations.

Targeted nerve biopsy: A technique in evolution
Marek, Tomáš , Stone, Jonathan J. , Amrami, Kimberly K. , Spinner, Robert J.

Mayo Clinic

Clinical Anatomy | April 27, 2018 | Volume: 31 | Issue: 8 | Pages: 1200-1204

10.1002/ca.23195 | PMID 29700865 Get It

LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins
Wei, Wei‐Qi, Li, Xiaohui , Feng, QiPing , Kubo, Michiaki , Peissig, Peggy , Karlson, Elizabeth W. , Jarvik, Gail P. , Shang, Ning , Larson, Eric , Shaffer, Christian M., Maeda, Shiro , Horikoshi, Momoko , Ritchie, Marylyn D. , Larson, Eric B. , Crosslin, David R. , Bland, Harris T. , Pacheco, Jennifer A. , Rasmussen‐Torvik, Laura J. , Cox, Nancy J. , Wilke, Russell A. , Rotter, Jerome I. , Momozawa, Yukihide , Roden, Dan M. , Krauss, Ronald M. , Denny, Joshua C. , Denny, Joshua C , Bland, Sarah T , Jarvik, Gail P , Wei, Wei-Qi , Rotter, Jerome I , Pacheco, Jennifer A , Kullo, Iftikhar J. , Lee, Ming Ta Michael , Edwards, Todd L. , Mosley, Jonathan D , Williams, Marc S , Cronkite, David , Hripcsak, George , Stein, Christoph , Roden, Dan M. , Feng, Qiping , Rasmussen-Torvik, Laura J

Mayo Clinic

Circulation | April 27, 2018 | Volume: 138 | Issue: 17 | Pages: 1839-1849

10.1161/circulationaha.117.031356 | PMID 29703846 Get It

Background: Coronary heart disease (CHD) is a leading cause of death globally. Although therapy with statins decreases circulating levels of low-density lipoprotein cholesterol and the incidence of CHD, additional events occur despite statin therapy in some individuals. The genetic determinants of this residual cardiovascular risk remain unknown. Methods: We performed a 2-stage genome-wide association study of CHD events during statin therapy. We first identified 3099 cases who experienced CHD events (defined as acute myocardial infarction or the need for coronary revascularization) during statin therapy and 7681 controls without CHD events during comparable intensity and duration of statin therapy from 4 sites in the Electronic Medical Records and Genomics Network. We then sought replication of candidate variants in another 160 cases and 1112 controls from a fifth Electronic Medical Records and Genomics site, which joined the network after the initial genome-wide association study. Finally, we performed a phenome-wide association study for other traits linked to the most significant locus. Results: The meta-analysis identified 7 single nucleotide polymorphisms at a genome-wide level of significance within the LPA/PLG locus associated with CHD events on statin treatment. The most significant association was for an intronic single nucleotide polymorphism within LPA/PLG (rs10455872; minor allele frequency, 0.069; odds ratio, 1.58; 95% confidence interval, 1.35–1.86; P =2.6×10 − 10 ). In the replication cohort, rs10455872 was also associated with CHD events (odds ratio, 1.71; 95% confidence interval, 1.14–2.57; P =0.009). The association of this single nucleotide polymorphism with CHD events was independent of statin-induced change in low-density lipoprotein cholesterol (odds ratio, 1.62; 95% confidence interval, 1.17–2.24; P =0.004) and persisted in individuals with low-density lipoprotein cholesterol ≤70 mg/dL (odds ratio, 2.43; 95% confidence interval, 1.18–4.75; P =0.015). A phenome-wide association study supported the effect of this region on coronary heart disease and did not identify noncardiovascular phenotypes. Conclusions: Genetic variations at the LPA locus are associated with CHD events during statin therapy independently of the extent of low-density lipoprotein cholesterol lowering. This finding provides support for exploring strategies targeting circulating concentrations of lipoprotein(a) to reduce CHD events in patients receiving statins.
Microarteriovenous Malformations—Value of Indocyanine Green Fluorescence and Nuances of Surgical Excision: 2-Dimensional Operative Video
Sorenson, Thomas J. , Carlstrom, Lucas, Carlstrom, Lucas P. , Lanzino, Giuseppe

Mayo Clinic

Operative Neurosurgery | April 27, 2018 | Volume: 16 | Issue: 1 | Pages: 117-117

10.1093/ons/opy102 | PMID 29718471 Get It

Abstract MicroAVMs (microarteriovenous malformation) are arteriovenous shunts with a nidus smaller than 1 centimeter. 1 They are typically diagnosed after hemorrhage. When the nidus is very small, diagnosis can be challenging even on catheter angiography and careful examination of the arterial and capillary phases is required to identify the early shunt. Because of the very small size, identification and localization of the actual AV shunt can be problematic during surgical exploration. Advances in frameless stereotactic neuronavigation and the introduction of intraoperative indocyanine green (ICG) fluorescein provide useful adjuncts in the surgical treatment of these relatively uncommon lesions. In this video, we present 2 cases which document the value of intraoperative ICG fluorescein as well as some of the surgical pitfalls in the treatment of these lesions.
0867 Sleep Duration and Hypertension among >700,000 Adults by Age and Sex: A Report of the National Healthy Sleep Awareness Project
Grandner, Michael A. , Mullington, Janet , Hashmi, Sarah D., Redeker, Nancy S. , Watson, Nathaniel F. , Morgenthaler, Timothy I.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A322-A322

10.1093/sleep/zsy061.866 Get It

Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family
Caulfield, Thomas R. , Richter, John E. , Brown, Emily , Mohammad, Ahmed N. , Judge, Daniel P. , Atwal, Paldeep S. , Atwal, Paldeep S , Caulfield, Thomas R , Judge, Daniel P

Mayo Clinic

Molecular Genetics & Genomic Medicine | April 27, 2018 | Volume: 6 | Issue: 4 | Pages: 666-672

10.1002/mgg3.401 | PMID 29700987 Get It

AbstractBackgroundHaploinsufficiency of TAB2 is known to cause congenital heart defects and cardiomyopathy due to its important roles in cardiovascular tissue, both during development and through adult life. We report a sibling pair displaying adult‐onset cardiomyopathy, hypermobility, and mild myopia. Our proband, a 39‐year‐old male, presents only with the above symptoms, while his 36‐year‐old sister was also notable for a ventricular septal defect in her infancy.MethodsWhole‐exome sequencing was utilized to identify the molecular basis of the phenotype found in two siblings. A molecular modeling technique that takes advantage of conformational sampling advances (Maxwell's demon molecular dynamics and Monte Carlo) were used to make a model of the mutant variant for comparative analytics to the wild‐type.ResultsExome sequencing revealed a novel, heterogeneous pathogenic variant in TAB2, c.1039 C>T (p.R347X), that was present in both individuals. This pathogenic variant removes just over half the residues from the TAB2 protein and severely impacts its functional ability, which we describe in detail.ConclusionsAnalysis of the proband's family showed a history of cardiomyopathy, but no congenital heart defects or connective tissue disease. We highlight the heterogeneity in phenotype of TAB2 pathogenic variants and confirm the pathogenicity of this new variant through neoteric protein modeling techniques.
0521 Perioperative Positive Airway Pressure Compliance in Obstructive Sleep Apnea Patients
Anders, G, Olson, Eric J.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A195-A195

10.1093/sleep/zsy061.520 Get It

0660 Higher Amounts of REM Sleep without Atonia Predict Phenoconversion To Defined Neurodegenerative Disorders in Idiopathic REM Sleep Behavior Disorder
McCarter, SJ, Feemster, John, McCarter, Allison R., Sandness, D., Timm, P C, Teigen, Luke, Silber, Michael H. , Louis, Erik K. St. , St Louis, E K , Boeve, Bradley F.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A245-A245

10.1093/sleep/zsy061.659 Get It

0682 A Novel, Highly Efficient REM Sleep without Atonia Visual Analysis Method for REM Sleep Behavior Disorder Diagnosis
Feemster, John, Timm, P C, Teigen, Luke, Louis, Erik K. St. , St Louis, E K , McCarter, Stuart J.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A253-A253

10.1093/sleep/zsy061.681 Get It

When all seems lost: management of refractory constipation—Surgery, rectal irrigation, percutaneous endoscopic colostomy, and more
Wilkinson‐Smith, Victoria , Bharucha, Adil E. , Emmanuel, Anton , Knowles, Charles H. , Yiannakou, Y., Corsetti, Maura , Wilkinson-Smith, V , Bharucha, A E , Corsetti, M , Yiannakou, Y.

Mayo Clinic

Neurogastroenterology & Motility | April 27, 2018 | Volume: 30 | Issue: 5 | Pages: No page available

10.1111/nmo.13352 | PMID 29700961 Get It

AbstractWhile the pharmacological armamentarium for chronic constipation has expanded over the past few years, a substantial proportion of constipated patients do not respond to these medications. This review summarizes the pharmacological and behavioral options for managing constipation and details the management of refractory constipation. Refractory constipation is defined as an inadequate improvement in constipation symptoms evaluated with an objective scale despite adequate therapy (ie, pharmacological and/or behavioral) that is based on the underlying pathophysiology of constipation. Minimally invasive (ie, rectal irrigation and percutaneous endoscopic colostomy) and surgical therapies are used to manage refractory constipation. This review appraises these options, and in particular, percutaneous endoscopic colostomy, which as detailed by an article in this issue, is a less invasive option for managing refractory constipation than surgery. While these options benefit some patients, the evidence of the risk: benefit profile for these therapies is limited.
1056 Exploring the Impact of a Sleep Enhancement Program in the Inpatient Environment on Patient Satisfaction: Lessons Learned
Moore, Wendy , Stellpflug, C, Ashbeck, R, Cutshall, S, Klevin, K, Marsh, Shona, Olson, Eric J. , Stellpflug, Courtney, Ashbeck, Rebecca, Marsh, S, Morgenthaler, Timothy I. , Lim, Kaiser G.

Mayo Clinic

Sleep | April 27, 2018 | Volume: 41 | Issue: suppl_1 | Pages: A393-A393

10.1093/sleep/zsy061.1055 Get It